At least 5 MR imaging with the same Gadolinium based contrast agent (either Dotarem or Multihance)
Have performed an unenhanced T1-weighted image before Gadolinium based contrast agent injection according to the OFSEP protocol
You may not be if
Never experienced other contrast agent then the one specified by the group to which they belong (either Dotarem, or Multihance)
Clareo Health | Evaluation of Potential Accumulation of Gadolinium (Dotarem and Multihance) in the French Observatory of Multiple Sclerosis (Www.Ofsep.Org/)
